Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

What's in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting

Urshila Durani, MDMPH, Narjust Duma, MD, Jessica A Slostad, MD, Christopher E. Wee, MD, Yael Kusne, MD PhD, Shruti Patel, MD, Carolina Bernabe, MD, Ana Velazquez, MD, Cynthia Brooke Woods, DO, Martina C. Murphy, MD, Miriam Knoll, MD, Shikha Jain, MD, Stephanie L. Graff, MD, Ariela L. Marshall, MD

Blood (2019) 134 (Supplement_1): 3411.

https://doi.org/10.1182/blood-2019-131484

Published: 2019

Journal Articles

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Narjust Duma, MD, Jonas Paludo, MD, Brian Kabat, B.S., Aaron Tande, MD, Kari G Chaffee, MS, Timothy G. Call, MD, Saad Sirop Kenderian, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Melissa C. Larson, M.S., Asher A. Chanan-Khan, MD, Michael Conte, PA-C, Susan Marie Schwager, Susan L Slager, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD

Blood (2017) 130 (Supplement 1): 4327.

https://doi.org/10.1182/blood.V130.Suppl_1.4327.4327

Published: 2017

Journal Articles

Gene Expression Profiling (GEP) As a Prognostic Indicator of Multiple Myeloma, Irrespective of Disease Stage, Prior Treatment and Prior Transplant - a Single Center Experience

Miguel Gonzalez Velez, MD, Tracy Andrews, PhD, Narjust Duma, MD, Ning Dong, MD, Badal Thakkar, MD MPH, Giselle Suero, MD PhD, Joshua R Richter, MD, David H. Vesole, MD PhD, David Siegel, MD PhD, Noa Biran, MD

Blood (2017) 130 (Supplement 1): 3062.

https://doi.org/10.1182/blood.V130.Suppl_1.3062.3062

Published: 2017

Journal Articles

Gene Expression Profiling (GEP) Is More Prognostic of OS and Post-ASCT PFS Compared to FISH in High-Risk Multiple Myeloma — a Single Center Experience

Miguel Gonzalez Velez, MD, Narjust Duma, MD, Badal Thakkar, MD MPH, Ning Dong, MD, Giselle Suero, MD PhD, David Siegel, MD PhD, Joshua R Richter, MD, David H. Vesole, MD PhD, Noa Biran, MD

Blood (2017) 130 (Supplement 1): 5369.

https://doi.org/10.1182/blood.V130.Suppl_1.5369.5369

Published: 2017

Journal Articles

Efficacy and Safety of Single-Agent Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera: A Meta-Analysis

Shijia Zhang, MD PhD, Yucai Wang, MD PhD, Larysa Sanchez, MD, Narjust Duma, MD, Victor Chang, MD

Blood (2015) 126 (23): 1622.

https://doi.org/10.1182/blood.V126.23.1622.1622

Published: 2015

NARROW

What's in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Gene Expression Profiling (GEP) As a Prognostic Indicator of Multiple Myeloma, Irrespective of Disease Stage, Prior Treatment and Prior Transplant - a Single Center Experience

Gene Expression Profiling (GEP) Is More Prognostic of OS and Post-ASCT PFS Compared to FISH in High-Risk Multiple Myeloma — a Single Center Experience

Efficacy and Safety of Single-Agent Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

What's in a Name? a Gender-Based Analysis of Speaker Introductions at the American Society of Hematology Annual Meeting

Invasive Aspergillosis in Chronic Lymphocytic Leukemia: Therapy and Outcomes

Gene Expression Profiling (GEP) As a Prognostic Indicator of Multiple Myeloma, Irrespective of Disease Stage, Prior Treatment and Prior Transplant - a Single Center Experience

Gene Expression Profiling (GEP) Is More Prognostic of OS and Post-ASCT PFS Compared to FISH in High-Risk Multiple Myeloma — a Single Center Experience

Efficacy and Safety of Single-Agent Ruxolitinib Therapy for Myelofibrosis and Polycythemia Vera: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only